JP2024544404A5 - - Google Patents

Info

Publication number
JP2024544404A5
JP2024544404A5 JP2024536283A JP2024536283A JP2024544404A5 JP 2024544404 A5 JP2024544404 A5 JP 2024544404A5 JP 2024536283 A JP2024536283 A JP 2024536283A JP 2024536283 A JP2024536283 A JP 2024536283A JP 2024544404 A5 JP2024544404 A5 JP 2024544404A5
Authority
JP
Japan
Prior art keywords
approximately
pharmaceutical composition
item
topical pharmaceutical
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024536283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544404A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081535 external-priority patent/WO2023114832A1/en
Publication of JP2024544404A publication Critical patent/JP2024544404A/ja
Publication of JP2024544404A5 publication Critical patent/JP2024544404A5/ja
Pending legal-status Critical Current

Links

JP2024536283A 2021-12-15 2022-12-14 Ｓｈｒ０３０２の安定な製剤 Pending JP2024544404A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163289780P 2021-12-15 2021-12-15
US63/289,780 2021-12-15
US202263370740P 2022-08-08 2022-08-08
US63/370,740 2022-08-08
PCT/US2022/081535 WO2023114832A1 (en) 2021-12-15 2022-12-14 Stable formulations of shr0302

Publications (2)

Publication Number Publication Date
JP2024544404A JP2024544404A (ja) 2024-11-29
JP2024544404A5 true JP2024544404A5 (https=) 2025-12-23

Family

ID=85018901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024536283A Pending JP2024544404A (ja) 2021-12-15 2022-12-14 Ｓｈｒ０３０２の安定な製剤

Country Status (9)

Country Link
US (2) US12161643B2 (https=)
EP (1) EP4447930A1 (https=)
JP (1) JP2024544404A (https=)
KR (1) KR20240125610A (https=)
AU (1) AU2022413551A1 (https=)
CA (1) CA3240662A1 (https=)
IL (1) IL313482A (https=)
MX (1) MX2024007437A (https=)
WO (1) WO2023114832A1 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
JP5732471B2 (ja) 2009-12-22 2015-06-10 レオ ファーマ アクティーゼルスカブ 溶媒混合物およびビタミンｄ誘導体から成る医薬品組成物または類似体
PT2796460T (pt) * 2011-12-21 2018-11-05 Shanghai hengrui pharmaceutical co ltd Derivado pirrole de anel heteroarilo de seis membros, método de preparação do mesmo e suas utilizações médicas
PT3006445T (pt) 2013-06-07 2018-01-09 Jiangsu Hengrui Medicine Co Bissulfato de inibidor de janus quinase (jak) e método de preparação para o mesmo
CN105566327A (zh) 2014-10-09 2016-05-11 江苏恒瑞医药股份有限公司 一种jak激酶抑制剂的硫酸氢盐的i型结晶及其制备方法
WO2016070697A1 (zh) 2014-11-05 2016-05-12 江苏恒瑞医药股份有限公司 一种jak激酶抑制剂的硫酸氢盐的结晶形式及其制备方法
CA3014090A1 (en) 2016-02-19 2017-08-24 Jiangsu Hengrui Medicine Co., Ltd. Pharmaceutical composition containing jak kinase inhibitor or pharmaceutically acceptable salt thereof
US20190060311A1 (en) 2017-08-24 2019-02-28 Aclaris Therapeutics, Inc. Compositions and methods for treatment of vitiligo
SG11202001706RA (en) 2017-10-27 2020-03-30 Theravance Biopharma R&D Ip Llc Pyrimidine compound as jak kinase inhibitor
WO2019096303A1 (zh) * 2017-11-20 2019-05-23 江苏恒瑞医药股份有限公司 一种局部给药的药物组合物及其制备方法
JP7268132B2 (ja) 2018-07-31 2023-05-02 エムシー２・セラピューティクス・リミテッド 局所用組成物
WO2020136650A1 (en) 2018-12-25 2020-07-02 Sol-Gel Technologies Ltd. Treatment of skin disorders with compositions comprising an egfr inhibitor
WO2020236950A1 (en) 2019-05-21 2020-11-26 Dauntless 1, Inc. Therapeutic microsphere formulations containing charged polymers
WO2022027041A1 (en) * 2020-07-28 2022-02-03 Arcutis Biotherapeutics, Inc. Topical formulation containing jak inhibitor and laureth-4
EP4237080A1 (en) 2020-10-29 2023-09-06 Arcutis Biotherapeutics, Inc. Methods for treating vitiligo lesions having improved efficacy
MX2023005763A (es) * 2020-11-17 2023-05-29 Arcutis Biotherapeutics Inc Composiciones y metodos para la administracion dermica profunda de farmacos.
CN114907353A (zh) * 2021-02-09 2022-08-16 明慧医药（杭州）有限公司 一种前药化合物及其制备方法和用途
CN114870016B (zh) 2022-04-21 2023-05-26 上海博悦生物科技有限公司 一种jak抑制剂的微乳泡沫剂及其应用

Similar Documents

Publication Publication Date Title
ES2618907T3 (es) Composiciones farmacéuticas en crema que comprenden oximetazolina
ES2308440T3 (es) Composiciones para el cuidado de la piel que contienen acido salicilico.
ES2240977T3 (es) Emulsiones topicas de ketoconazol.
JP3991063B2 (ja) 皮膚外用剤
KR100358421B1 (ko) 세린프로테아제억제제를포함하는국소용제제
JP6512599B2 (ja) 外用医薬組成物
JP2005239705A (ja) 局所的抗菌性製剤
US20050137164A1 (en) Diclofenac compositions for the treatment of skin disorders
TWI794222B (zh) 組成物在製備治療睡眠障礙的藥劑的用途
US20110076261A1 (en) Antifungal Drug Delivery System
US20230293492A1 (en) Methods and compositions for treating cutaneous fungal infections
JP2024544404A5 (https=)
JP2000355515A (ja) 化粧料組成物
US20230312495A1 (en) New isobutyramide derivatives, cosmetic and/or dermatological preparations containing said compounds, and their use for the prophylaxis and treatment of sensitive, in particular inflamed skin or inflammatory skin conditions
ES2263781T3 (es) Composicion dermatologica comprendiendo acido nicotinico una amida, y una base esfingoide.
GB2365770A (en) Antifungal ketoconazole composition for topical use
US20240148647A1 (en) An eflornithine composition for inhibiting hair growth
JP5569918B2 (ja) 皮膚外用剤
JP2002531474A (ja) デオドラント化粧品組成物
JP5170973B2 (ja) 皮膚外用剤
CN103189041B (zh) 手指甲或脚趾甲生长促进用组合物
JP7610359B2 (ja) 外用組成物
JP3713406B2 (ja) 皮膚外用ゲル製剤
CN103732224A (zh) 用于眼睫毛生长的组合物
JPH09263510A (ja) 乳化組成物